Solvias buys Confarma for EU pharma quality control capacity
Solvias has bought quality control services firm Confarma, expanding its analytical offering and adding capacity in several EU markets.
Archives for February 4, 2013
FDA to Release Long-Awaited Guidance on CMO Agreements, Biosimilars in 2013
Highly sought-after guidance on quality agreements for contract manufacturing organizations (CMOs) and biosimilar developers is expected in 2013, according to a list of future guidance documents released by the US Food and Drug Administration (FDA).
Ben Venue's consent decree was necessary says FDA; limited manufacturing to continue
The Consent decree was a necessary response to Ben Venue's long history of quality failures says the US FDA.
Bioavailability drives Patheon and Catalent investments
Patheon says expanding its UK facility is necessary in offering its Solupath services to a European and Asian market.